Directory

ALDERLEY PARK


Glasshouse is a rare haven for innovative, hi-tech companies, offering contemporary office space just outside Manchester. In a crowded, hectic world, where space is scarce, Glasshouse bucks the trend, with generous workspaces set in beautiful, extensive grounds, surrounded by exceptional facilities. More than this, it’s home to a collaborative community. A place where like-minded, future-facing businesses live, breathe and participate under one roof.


“At Glasshouse you can choose as much or as little space as you like with a choice of layouts and configurations. Whether you are looking for co-working, serviced, managed or leased spaces, Glasshouse brings together a vibrant, thriving community of like-minded, forward-thinking businesses. It’s a place to make new connections and partnerships; to be inspired by the people around you. With ideas and creativity flowing through the corridors into the central atrium, Glasshouse embodies a spirit of innovation. What’s more, exceptional amenities include a new gym and sports complex, coffee shops, restaurant, new pub opening soon, plus scenic walking, running and cycling routes.”


Glasshouse offers high specification office space whatever your needs. From coworking to serviced offices, made and managed offices and leased offices, flexibility is at the core. From 1 desk to 60,000 sq ft floorplates and your very own office balcony overlooking the atrium, the possibilities are endless.


For pricing information, please contact ALDERLY PARK.


Example companies


Facts for Life

Facts for Life are a niche educational provider of scientific enrichment programmes, with a track record in developing a deeper breadth of knowledge that empowers students to make informed life choices.

Cyprotex

Cyprotex specialises in preclinical ADMET services utilising both in vitro and in silico technologies and is based both in the UK and USA.

Absynth Biologics Ltd

Absynth Biologics discovers and develops vaccines and antibodies to prevent and treat bacterial infections based on proprietary, non-conventional platform for identifying novel protein antigen that harness the immune system and that use a dual-action mechanism.